Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis. (Q53809365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

prostate adenocarcinoma

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Antonio B. Porcaro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Aldo Scarpa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giuseppe Zamboni

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hemamali Samaratunga

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

F Massari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Anna Caliò

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

20

Giampaolo Tortora

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

Walter Artibani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Chiara Ciccarese

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Luca Cima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giovanni Novella

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Teodoro Sava

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Albino Eccher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Claudio Ghimenton

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Francesco Bertoldo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nicola Sperandio

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Camillo Porta

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Vincenzo Bronte

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marco Chilosi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giuseppe Bogina

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Guido Martignoni

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Matteo Brunelli

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

345-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11523-015-0396-3

29 February 2020

exact match

0 references

cites work

The evolving role of immunotherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Beyond sipuleucel-T: immune approaches to treating prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Regulatory T cells and cancer: an undesired tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Nivolumab in previously untreated melanoma without BRAF mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Abiraterone and increased survival in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Radium-223 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Activation of thymic regeneration in mice and humans following androgen blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Alpha emitter radium-223 and survival in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Imbalance of regulatory T cells in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

CD4 regulatory T cells in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-015-0396-3

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

21 January 2018

1 reference

12 December 2020

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

1 reference

12 December 2020

Abiraterone in metastatic prostate cancer.

1 reference

12 December 2020

Enhanced production of B lymphocytes after castration.

1 reference

12 December 2020

10.1007/S11523-015-0396-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26566945%20AND%20SRC:MED&resulttype=core&format=json

release_k3mlnnq7qvbsvhk5asn33uglwy

29 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k3mlnnq7qvbsvhk5asn33uglwy

24 November 2022

mapped directly with Wikidata item

1 reference